Quantcast
Last updated on April 16, 2014 at 1:21 EDT

Latest MedImmune Stories

2011-11-30 04:00:00

LONDON, Nov. 30, 2011 /PRNewswire/ -- Cognizant (NASDAQ: CTSH), a leading provider of consulting, technology, and business process outsourcing services, today announced a multi-year agreement with AstraZeneca to deliver comprehensive biostatistics and medical reporting services to generate clinical study reports. Under the agreement, Cognizant will provide centralized statistical programming, statistical analysis, medical writing, and document publishing services, spanning the entire...

2011-11-29 12:00:00

ALEXANDRIA, Va., Nov. 29, 2011 /PRNewswire/ -- As cold and flu season is upon us, text4baby - a free text messaging program for pregnant and new moms - shared information today from the service's first-ever interactive educational module, showing how the service can quickly and efficiently gather important data on how moms make choices about taking steps to prevent the flu. The goal of this new module was to introduce interactivity into the text4baby system - specifically...

2011-11-21 09:30:00

Strategic collaboration agreement will bring scientists together to work toward new biologic options for cancer and other diseases ANN ARBOR, Mich., Nov. 21, 2011 /PRNewswire-USNewswire/ -- Leaders from the University of Michigan Medical School and MedImmune, the global biologics arm of AstraZeneca, have signed a new agreement to work together on a broad range of projects. The three-year strategic collaboration will bring scientists from one of the nation's top medical research...

2011-11-14 16:00:00

QUEBEC CITY, Nov. 14, 2011 /PRNewswire/ - Medicago Inc. (TSX: MDG), a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced its operational and financial results for the third quarter ended September 30, 2011. The Company's financial statements and management report are available at www.sedar.com and at www.medicago.com. "This was another quarter of progress on...

2011-11-14 10:00:00

GAITHERSBURG, Md., Nov. 14, 2011 /PRNewswire/ -- MedImmune today announced the winners of its 6th Annual Research Abstract Competition highlighting the work of the next generation of scientific leaders performing research in the areas of respiratory, inflammatory and autoimmune (RIA) disease. Graduate students and postdoctoral fellows were invited to submit abstracts about RIA research as part of a competition sponsored by MedImmune, the global biologics arm of AstraZeneca. First prize of...

2011-11-10 06:00:00

RALEIGH, North Carolina and QUEBEC CITY, Quebec, Nov. 10, 2011 /PRNewswire/ - Medicago U.S.A. Inc., a wholly owned subsidiary of Medicago Inc. (TSX: MDG), a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that company executives, along with North Carolina Governor Beverly Perdue, U.S. Senator Richard Burr and Congressman David Price, are holding an...

2011-11-09 09:00:00

COPENHAGEN, Denmark and SEATTLE, Nov. 9, 2011 /PRNewswire/ -- Single-use technologies are widely accepted in the biomanufacturing of biological therapeutics and vaccines. Pharma/biopharmaceutical companies, contract manufacturing organizations, engineering firms, and leading technology suppliers are embracing advances in disposable technologies. Over 120 delegates from the biomanufacturing industry attended a two-day 'Single-Use Technology Seminar' in Copenhagen on 25-26th October. The...

2011-11-08 06:00:00

GAITHERSBURG, Md., Nov. 8, 2011 /PRNewswire/ -- MedImmune, the global biologics arm of AstraZeneca, today announced that the company's expansion project at its Frederick, Md., Manufacturing Center (FMC) won the International Society for Pharmaceutical Engineering's overall 2011 Facility of the Year Award. This is the first time MedImmune has won this prestigious internationally renowned accolade. The annual Facility of the Year Awards (FOYA), sponsored by the ISPE, INTERPHEX and...

2011-10-31 07:00:00

PORTLAND, Ore., Oct. 31, 2011 /PRNewswire/ -- AgonOx today announced that it has entered into an exclusive global partnership with MedImmune, the global biologics arm of AstraZeneca, to develop agonists using its OX40 platform. MedImmune will lead further preclinical and clinical studies of this tumor-specific T-cell immunity stimulator for the potential treatment of cancer. "We are very pleased to collaborate with MedImmune to advance our OX40 agonist programs," said AgonOx CEO Llew...

2011-10-26 06:50:00

BOSTON, Oct. 26, 2011 /PRNewswire/ -- 13 leading industry speakers will present at CBI's 2nd Annual Pharma/Bio Boot Camp on Electronic Trial Master Files on November 14-15, 2011 in Philadelphia. Nearly 100 TMF professionals convene for this interactive and educational exploration of the major shift taking place in the clinical trials -- moving from paper documentation to electronic files. Often called the heart of a clinical trial, the TMF is re-examined as it moves to a more effective...